ANEBOTCPharmaceutical PreparationsFiscal year ends June 30
Anebulo Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Dec 31, 2025Last filing: 10-Q on Feb 12, 2026
$0.00+0.00 (+75.00%)
Close on Oct 19, 2026
- Market cap
- $28.76K
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Mar 31, 2026, from 13F filings
Held by institutions
0.0%
0M of 41M shares
Institutional holders
0
0 new, 18 sold out
Net institutional buying
-22M
In Q1 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 3,547,398 | 8.53% | 13G (passive) amendment | Dec 31, 2025 |
| Nathaniel August | 2,525,252 | 6.15% | 13G (passive) | Dec 31, 2024 |
| Aron R. English | 21,929,880 | 51.10% | 13D (active) amendment | Feb 24, 2025 |
Top institutional holders
13F holdings as of Dec 31, 2025
| Holder | Shares | % of ANEB | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| 22NW, LP | 15,467,300 | 37.92% | $84.76M | – | 35.68% |
| Nantahala Capital Management, LLC | 3,036,325 | 7.44% | $3.07M | – | 0.10% |
| Mangrove Partners | 2,525,252 | 6.19% | $2.55M | – | 0.21% |
| Vanguard Group Inc | 435,821 | 1.07% | $440.18K | +129,281 | 0.00% |
| Morgan Stanley | 399,404 | 0.98% | $403.40K | – | 0.00% |
| Geode Capital Management, LLC | 160,760 | 0.39% | $162.48K | −13,348 | 0.00% |
| Rangeley Capital, LLC | 50,000 | 0.12% | $50.50K | +30,000 | 0.04% |
| Renaissance Technologies LLC | 25,098 | 0.06% | $25.35K | −3,402 | 0.00% |
| Citadel Advisors LLC | 24,239 | 0.06% | $24.48K | New | 0.00% |
| BlackRock, Inc. | 23,790 | 0.06% | $24.03K | −270 | 0.00% |
| Northern Trust Corp | 21,994 | 0.05% | $22.21K | −2,399 | 0.00% |
| Ikarian Capital, LLC | 17,736 | 0.04% | $17.91K | −139,984 | 0.00% |
| State Street Corp | 12,768 | 0.03% | $12.90K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 3,230 | 0.01% | $3.26K | +1,480 | 0.00% |
| UBS Group AG | 2,334 | 0.01% | $2.36K | +2,114 | 0.00% |
| JPMorgan Chase & Co | 2,253 | 0.01% | $2.28K | −2,023 | 0.00% |
| Bank Of America Corp /De/ | 382 | 0.00% | $386 | −509 | 0.00% |
| FNY Investment Advisers, LLC | 100 | 0.00% | $0 | +5 | 0.00% |
| Royal Bank of Canada | 30 | 0.00% | $0 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q1 2026 | 0 | 0M | 0.0% | 0 / 0 | 0 / 18 | 0M | 22M |
| Q4 2025 | 19 | 22M | 54.5% | 2 / 5 | 7 / 4 | 0M | 0M |
| Q3 2025 | 21 | 22M | 54.5% | 9 / 4 | 3 / 6 | 0M | 1M |
| Q2 2025 | 18 | 23M | 55.4% | 2 / 6 | 3 / 2 | 0M | 0M |
| Q1 2025 | 18 | 23M | 55.5% | 4 / 5 | 4 / 1 | 0M | 0M |
| Q4 2024 | 15 | 23M | 55.3% | 2 / 6 | 5 / 0 | 15M | 0M |
| Q3 2024 | 13 | 7M | 18.0% | 2 / 3 | 4 / 1 | 0M | 1M |
| Q2 2024 | 13 | 8M | 19.2% | 1 / 5 | 3 / 3 | 1M | 1M |
| Q1 2024 | 15 | 8M | 19.9% | 4 / 3 | 5 / 3 | 0M | 1M |
| Q4 2023 | 14 | 8M | 20.1% | 4 / 5 | 3 / 2 | 2M | 1M |
| Q3 2023 | 12 | 7M | 17.3% | 0 / 5 | 2 / 0 | 0M | 0M |
| Q2 2023 | 12 | 7M | 17.2% | 3 / 2 | 2 / 1 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Cunningham, Richard Anthony | Chief Executive Officer, Director | – | – | Apr 7, 2025 |
| Kenneth C. Cundy | Chief Scientific Officer | – | – | Apr 7, 2025 |
| Areta Kupchyk | Director | – | – | Apr 7, 2025 |
| Joseph F. Lawler | Director, 10% owner | 12,000,000 | 29.42% | Apr 7, 2025 |
| Kenneth Lin | Director | – | – | Apr 7, 2025 |
| Nathaniel Calloway | Director | – | – | Apr 7, 2025 |
| Bimal R. Shah | Director | – | – | Apr 7, 2025 |
| Aron R. English | Director, 10% owner | 20,121,828 | 49.34% | Apr 7, 2025 |
| Jason Aryeh | Director | – | – | Apr 7, 2025 |
| 22NW Fund, LP | 10% owner | 8,017,241 | 19.66% | Dec 26, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Aron R. English Director, 10% owner | Dec 23, 2024 | Buy | +10,101,010 | $0.99 | $10.00M | 15,467,300 |
| 22nw, Lp 10% owner | Dec 18, 2023 | Gift | +300,000 | – | – | 5,366,290 |
| 22nw, Lp 10% owner | Dec 18, 2023 | Gift | −300,000 | – | – | 0 |
| 22nw, Lp 10% owner | Nov 13, 2023 | Award | +300,000 | – | – | 300,000 |
| Aron R. English Director, 10% owner | Sep 28, 2022 | Award | +1,703,577 | $2.81 | $4.79M | 5,066,290 |
| 22NW Fund, LP – | Dec 17, 2021 | Buy | +400 | $6.59 | $2.64K | 3,362,713 |
| 22NW Fund, LP – | Dec 14, 2021 | Buy | +412 | $5.90 | $2.43K | 3,362,313 |
| 22NW Fund, LP – | Dec 3, 2021 | Buy | +4,500 | $5.93 | $26.69K | 3,361,901 |
| 22NW Fund, LP – | Dec 2, 2021 | Buy | +13,836 | $5.30 | $73.33K | 3,357,401 |
| 22NW Fund, LP 10% owner | May 6, 2021 | Award | +714,250 | $7.00 | $5.00M | 3,343,565 |
| 22nw, Lp 10% owner | May 6, 2021 | Award | +714,286 | $7.00 | $5.00M | 3,343,601 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.